Cleveland Clinic has opened a new community pharmacy at South Pointe Hospital in Warrensville Heights.  The pharmacy, located in the South Pointe Medical Office, aims to address growing concerns over pharmacy access in Cuyahoga County’s eastern suburbs, where many neighborhoods…

Amid rising COVID-19 infections and mounting reports of vaccine inaccessibility, Sen. Ed Markey sent letters to the CEOs of CVS Health and Walgreens asking why updated vaccines are difficult to attain in many states.  Mr. Markey, who chairs the Senate…

Two New York residents have filed a lawsuit against CVS after the company’s pharmacy benefit manager, Caremark, denied coverage for Zepbound in favor of Wegovy.  The plaintiffs — Dennis Larkin of Mahopac, N.Y., and Danielle Gosline of Auburn, N.Y. —…

The FDA said Sept. 4 it will release complete response letters, or product rejection letters, “promptly after they are issued” to manufacturers.  The agency also published 89 previously unreleased complete response letters related to pending or withdrawn applications. The letters…

For the first time, Charlottesville, Va.-based UVA Health’s outpatient pharmacies have dispensed more than 1 million medications in a single year, a milestone driven by growing patient demand and expanded pharmacy services.  The health system opened new retail pharmacy locations,…

Here are five new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists: 

Novo Nordisk’s popular weight loss drug, Wegovy, is the first and only GLP-1 medication approved to treat metabolic associated steatohepatitis, a serious condition marked by liver scarring.  The FDA granted the approval Aug. 15.  Injectable GLP-1 drugs primarily treat obesity…

The statistics are clear: GLP-1 medications can have a dramatic effect on cardiovascular health.  Recent research has shown both semaglutide and tirzepatide — the active ingredients in Ozempic and Wegovy, and Mounjaro and Zepbound, respectively — can significantly reduce the…

A commonly available nasal spray may significantly reduce the risk of COVID-19 infections, according to clinical trial results.  Researchers from Saarland University Hospital in Germany led the study, the results of which were published Sept. 2 in JAMA Internal Medicine.…

Eli Lilly has partnered with Chinese digital healthcare platform JD Health International to sell its GLP-1s to patients online, Bloomberg reported Aug. 29.  The collaboration will offer a streamlined, one-stop service through JD Health, including online consultations, prescriptions, drug delivery…